BSR | Introduction 1 This report examines how arti昀椀cial human rights issues associated with intelligence (AI) technologies are AI by establishing internal teams driving change within the healthcare and advisory boards dedicated to industry and the associated human responsible technology use, such as rights challenges and opportunities. Merck KGaA’s Digital Ethics Advisory Panel, or by setting out AI principles, As the healthcare industry continues its digital such as Novartis’ commitment to transformation, providers need to consider the ethical and responsible use of the impacts of AI for three main reasons: AI systems, other companies remain Human RIghts unaware of, or unprepared to deal with, the emergent risks and impacts Technological transformation brings arising from the development and complex, nuanced, and systemwide risks and deployment of AI technologies. opportunities for the realization of human rights. These risks and opportunities are With this context, BSR has started related to both the design and development engaging healthcare companies of technologies as well as how technologies and the technology companies are deployed and used by companies. that provide AI services to them to better understand the current Evolving Regulatory Environment use cases of AI, associated human Changes in the regulatory landscape, including rights risks, and the processes and the EU’s proposed Corporate Sustainability policies in place to address those Due Diligence Directive and Arti昀椀cial risks. This primer summarizes our Intelligence Act, signal that companies outside 昀椀ndings and observations from of the technology industry will need to have these engagements and makes a better understanding of the human rights preliminary recommendations to impacts of the AI solutions they deploy. It companies in the healthcare industry is noteworthy that companies using AI, not on how they can address the human just companies selling AI, are considered in rights impacts of AI in healthcare. scope for the proposed EU AI regulation. This report is not intended to Lack of Company Processes provide a comprehensive assessment of human rights impacts across In initial engagements with healthcare the healthcare industry. Rather, it companies, BSR has observed that companies introduces salient human rights issues have varying degrees of maturity in respect to associated with the increased use their AI governance processes. While some of AI technology in the healthcare companies have begun to address ethical and industry. The 昀椀ndings outlined in this